Clinical Trial Update: Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder

View source ↗

Summary

This completed observational study evaluated whether use of atypical antipsychotics in a naturalistic setting improves quality of life for people with bipolar d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Atypical antipsychotics

Snippet

Sponsor: AstraZeneca | Conditions: Naturalistic, Observational | Status: COMPLETED